News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
227 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Business
Ligand Reports Third Quarter 2017 Financial Results
Total revenues for the third quarter of 2017 were $33.4 million, compared with $21.6 million for the same period in 2016.
November 9, 2017
·
23 min read
Drug Development
Alnylam Announces Successful Outcome Following FDA Type A Meeting to Discuss Fitusiran Program in Hemophilia
With the completion of the Type A meeting, the FDA will now consider removal of the clinical hold upon final review of the amended protocols and other trial materials.
November 9, 2017
·
9 min read
Business
Synergy Pharmaceuticals Reports Third Quarter 2017 Financial Results and Business Update
Total net sales were $5.0 million for the third quarter of 2017, a 117.4% increase over the prior quarter.
November 9, 2017
·
10 min read
Business
IntelGenx Reports Third Quarter 2017 Financial Results
Total revenues for the three-month period ended September 30, 2017 amounted to $1.3 million, compared to $1.8 million for the three-month period ended September 30, 2016.
November 9, 2017
·
5 min read
Sosei to Advance Clinical Development in Japan of HTL0018318 in Patients With Dementia With Lewy Bodies (DLB)
Initially, Sosei will undertake a Phase 2 proof-of-concept monotherapy study, expected to begin in Japan in 2018.
November 9, 2017
·
5 min read
Business
Perrigo Company Reports Third Quarter 2017 Financial Results
Delivered third quarter 2017 GAAP (“reported”) net sales of $1.2 billion, reported net income of $45 million and reported diluted earnings per share (“EPS”) of $0.31 compared to a loss per share of $11.10 last year.
November 9, 2017
·
62 min read
Drug Development
Medivir: MIV-711 Phase IIa Osteoarthritis Study Data Presented as a Late Breaking Poster at the Annual Meeting of the American College for Rheumatology
ACR took place from November 3-8 in San Diego, USA.
November 9, 2017
·
5 min read
Pharm Country
Alexion Employees Volunteer Together to Enhance Their Local Communities during Second Annual Global Day of Service
Alexion announced that more than 1,300 employees are rallying together in support of community service initiatives focused on health, wellness, and education as part of the Company’s second annual Global Day of Service.
November 9, 2017
·
6 min read
Business
Aralez Announces Third Quarter 2017 Financial Results And Achieves Profitability on an Adjusted EBITDA Basis for the First Time in the Third Quarter
Based on the Company’s preliminary 2018 outlook, the Company is expected to transition into a growth phase of its corporate evolution and pivot into a profitable (on an Adjusted EBITDA basis) and growth Company.
November 9, 2017
·
38 min read
Business
Galmed Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update
A conference call and webcast is scheduled for oday at 8:30 a.m. ET / 5:30 a.m. PT.
November 9, 2017
·
18 min read
Previous
18 of 23
Next